Digital Pathology
Lumea to Incorporate Myriad Genetics Cancer Tests Into Digital Pathology Platform
Under the collaboration, the firms will make Myriad's Prolaris prostate cancer and MyRisk hereditary cancer tests available through Lumea's BxLink digital pathology platform.
PathAI, Discovery Life Sciences Form Biospecimen Analysis Alliance
As part of their partnership, Discovery will integrate PathAI's image management technology into its biospecimens business.
Coined SEQUOIA, the AI model was able to predict expression profiles for thousands of genes in cancer samples using whole-slide images.
Aignostics Raises $34M in Series B Round
The company develops AI technologies to analyze a range of pathology data derived from tissue samples for biopharma clients.
Owkin, AstraZeneca Partner to Develop AI-Based Breast Cancer Prescreening Tool
The solution will use Owkin's data network and artificial intelligence to prescreen for gBRCA mutations in breast cancer directly from digital pathology slides.